37,006 Shares in Orthofix Medical Inc. (NASDAQ:OFIX) Acquired by Susquehanna Fundamental Investments LLC

Susquehanna Fundamental Investments LLC bought a new position in shares of Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 37,006 shares of the medical device company's stock, valued at approximately $646,000. Susquehanna Fundamental Investments LLC owned 0.10% of Orthofix Medical at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of OFIX. JPMorgan Chase & Co. grew its holdings in shares of Orthofix Medical by 244.1% during the fourth quarter. JPMorgan Chase & Co. now owns 290,351 shares of the medical device company's stock worth $5,070,000 after purchasing an additional 205,972 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Orthofix Medical by 31.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 659,475 shares of the medical device company's stock worth $11,515,000 after buying an additional 159,177 shares in the last quarter. Emerald Advisers LLC grew its holdings in Orthofix Medical by 12.2% during the 4th quarter. Emerald Advisers LLC now owns 822,377 shares of the medical device company's stock worth $14,359,000 after acquiring an additional 89,717 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new stake in Orthofix Medical in the 4th quarter valued at about $1,286,000. Finally, Teacher Retirement System of Texas raised its stake in shares of Orthofix Medical by 90.0% in the fourth quarter. Teacher Retirement System of Texas now owns 135,009 shares of the medical device company's stock worth $2,357,000 after acquiring an additional 63,939 shares during the last quarter. 89.76% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on OFIX shares. Roth Mkm reiterated a "buy" rating and issued a $22.00 price objective on shares of Orthofix Medical in a research report on Wednesday, February 26th. Canaccord Genuity Group reiterated a "buy" rating and set a $24.00 price target on shares of Orthofix Medical in a research report on Wednesday, February 26th. Finally, StockNews.com upgraded shares of Orthofix Medical from a "hold" rating to a "buy" rating in a report on Tuesday, February 25th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $23.33.

Insiders Place Their Bets

In other news, insider Lucas Vitale sold 4,287 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $16.60, for a total transaction of $71,164.20. Following the completion of the transaction, the insider now owns 135,317 shares in the company, valued at approximately $2,246,262.20. This represents a 3.07 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jorge Andres Cedron sold 3,816 shares of the company's stock in a transaction that occurred on Wednesday, April 16th. The shares were sold at an average price of $13.31, for a total transaction of $50,790.96. Following the sale, the insider now owns 42,500 shares in the company, valued at $565,675. The trade was a 8.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 8,475 shares of company stock worth $128,065. Insiders own 2.60% of the company's stock.

Orthofix Medical Price Performance

NASDAQ:OFIX traded down $1.48 during mid-day trading on Tuesday, reaching $12.06. The stock had a trading volume of 1,661,104 shares, compared to its average volume of 260,702. Orthofix Medical Inc. has a 12 month low of $11.13 and a 12 month high of $20.73. The stock has a market capitalization of $470.61 million, a PE ratio of -3.85 and a beta of 0.87. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.39 and a quick ratio of 1.11. The stock has a 50-day simple moving average of $15.27 and a two-hundred day simple moving average of $17.03.

Orthofix Medical (NASDAQ:OFIX - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The medical device company reported ($1.35) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by ($1.18). Orthofix Medical had a negative net margin of 15.18% and a negative return on equity of 21.25%. On average, equities analysts anticipate that Orthofix Medical Inc. will post -2.81 earnings per share for the current year.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.